Ganga Pharmaceuticals Valuation
Is 539680 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 539680 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 539680's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 539680's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 539680?
Key metric: As 539680 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 539680's PE Ratio? | |
|---|---|
| PE Ratio | 133.2x |
| Earnings | ₹544.59k |
| Market Cap | ₹72.55m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3.1x |
| Enterprise Value/EBITDA | -78x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 539680's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 26.5x | ||
531762 Unjha Formulations | 15.5x | n/a | ₹124.0m |
WALPAR Walpar Nutritions | 17.3x | n/a | ₹428.2m |
524703 Sandu Pharmaceuticals | 36.1x | n/a | ₹548.6m |
542248 Deccan Health Care | 37x | n/a | ₹572.2m |
539680 Ganga Pharmaceuticals | 133.2x | n/a | ₹72.5m |
Price-To-Earnings vs Peers: 539680 is expensive based on its Price-To-Earnings Ratio (133.2x) compared to the peer average (26.5x).
Price to Earnings Ratio vs Industry
How does 539680's PE Ratio compare vs other companies in the IN Personal Products Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 539680 is expensive based on its Price-To-Earnings Ratio (133.2x) compared to the Asian Personal Products industry average (24.9x).
Price to Earnings Ratio vs Fair Ratio
What is 539680's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 133.2x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 539680's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Emami
₹278.9b
Manufactures and markets personal and healthcare products in India and internationally.
EMAMILTD
₹638.85
7D
-0.6%
1Y
26.8%
Godrej Consumer Products
₹1.2t
A fast-moving consumer goods company, engages in the manufacture and marketing of personal care and home care products in India, Africa, Indonesia, the Middle East, the United States of America, and internationally.
532424
₹1,193.20
7D
1.5%
1Y
18.2%
Godrej Consumer Products
₹1.2t
A fast-moving consumer goods company, engages in the manufacture and marketing of personal care and home care products in India, Africa, Indonesia, the Middle East, the United States of America, and internationally.
GODREJCP
₹1,192.30
7D
1.5%
1Y
18.1%